ACE inhibitor pathway (Bos taurus)

From WikiPathways

Revision as of 21:13, 9 May 2013 by MaintBot (Talk | contribs)
Jump to: navigation, search
ArcPathVisio Brace Ellipse EndoplasmicReticulum GolgiApparatus HexagonPathVisio MimDegradation Mitochondria Octagon PentagonPathVisio Rectangle RoundedRectangle SarcoplasmicReticulum TriangleEquilateralEast TrianglePathVisio none Cell MembraneAGTRENACEKNG1ACENOS3BDKRB2ACE InhibitorAngiotensin IIAngiotensin IBradykininAldosteroneAGTR2AGTR1Name: ACE Inhibitor PathwayOrganism: Bos taurus


Description

The renin-angiotensin-aldosterone system (RAAS) is central to the control of blood pressure and the target of several types of anti-hypertensive drugs. This pathway depicts a simplified representation of the pharmacodynamics (PD) of RAAS-acting drugs including candidate genes for the pharmacogenomics (PGx) of ACE inhibitors, angiotensin receptor blockers (ARBs), renin inhibitor aliskiren and aldosterone receptor antagonists. Source: PharmGKB (http://www.pharmgkb.org/do/serve?objId=PA2023&objCls=Pathway)

Comments

HomologyConvert 
This pathway was inferred from Homo sapiens pathway WP554(r30178) with a 77% conversion rate.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Image:Curated.pngReview changes for Approved
Image:Featured.pngReview changes for Featured
Homology Converted
Image:MissingXref.pngAnnotate nodes

Ontology Terms

 

Bibliography

View all...
  1. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H; ''The emerging role of ACE2 in physiology and disease.''; J Pathol, 2007 PubMed Europe PMC Scholia
  2. Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A; ''Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?''; Expert Opin Pharmacother, 2007 PubMed Europe PMC Scholia
  3. Ferreira AJ, Raizada MK; ''Are we poised to target ACE2 for the next generation of antihypertensives?''; J Mol Med, 2008 PubMed Europe PMC Scholia
  4. Bassett MH, White PC, Rainey WE; ''The regulation of aldosterone synthase expression.''; Mol Cell Endocrinol, 2004 PubMed Europe PMC Scholia
  5. McDowell SE, Coleman JJ, Ferner RE; ''Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.''; BMJ, 2006 PubMed Europe PMC Scholia
  6. Maron BA, Leopold JA; ''Mineralocorticoid receptor antagonists and endothelial function.''; Curr Opin Investig Drugs, 2008 PubMed Europe PMC Scholia
  7. Batenburg WW, Jan Danser AH; ''The (pro)renin receptor: a new addition to the renin-angiotensin system?''; Eur J Pharmacol, 2008 PubMed Europe PMC Scholia
  8. Weir MR; ''Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?''; Clin Ther, 2007 PubMed Europe PMC Scholia
  9. Schwartz GL, Turner ST; ''Pharmacogenetics of antihypertensive drug responses.''; Am J Pharmacogenomics, 2004 PubMed Europe PMC Scholia
  10. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W; ''Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.''; Kidney Int, 2006 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
117471
Approved
Featured
view10:58, 21 May 2021EweitzModified title
105956view11:48, 16 August 2019MaintBotHMDB identifier normalization
96331view09:34, 8 March 2018Mkutmonremove redundant ontology tag
96330view09:34, 8 March 2018MkutmonOntology Term : 'angiotensin signaling pathway' added !
96329view09:33, 8 March 2018MkutmonUpdated homology conversion
80846view15:28, 30 June 2015Mkutmonhomology conversion
79145view05:51, 5 March 2015KhanspersModified title
79144view05:42, 5 March 2015KhanspersUpdated conversion from Hs
71401view19:00, 17 October 2013MaintBotAutomated update of data sources
67016view09:53, 26 June 2013Christine ChichesterOntology Term : 'ACE inhibitor drug pathway' added !
63332view21:13, 9 May 2013MaintBotUpdated to 2013 gpml schema
57076view20:11, 20 January 2013Egonw
40511view19:29, 1 March 2011MaintBotRemoved redundant pathway information and comments
35048view09:36, 11 February 2010Thomasremoved genmapp notes (invalid link)
35040view09:29, 11 February 2010ThomasModified description
33754view23:59, 8 December 2009MaintBotAutomatic update of empty xrefs
31672view11:42, 14 August 2009MaintBotFixed group labels
30602view22:16, 29 July 2009MaintBotNew pathway

External references

DataNodes

View all...
Name  ↓Type  ↓Database reference  ↓Comment  ↓
ACE InhibitorMetabolite
ACEGeneProduct614289 (Entrez Gene)
AGTGeneProduct527114 (Entrez Gene)
AGTR1GeneProduct281607 (Entrez Gene)
AGTR2GeneProduct407157 (Entrez Gene)
AldosteroneMetaboliteC01780 (Kegg Compound)
Angiotensin IMetabolite3081372 (PubChem-compound)
Angiotensin IIMetaboliteHMDB01035 (HMDB)
BDKRB2GeneProduct538896 (Entrez Gene)
BradykininMetaboliteHMDB04246 (HMDB)
KNG1GeneProduct280833 (Entrez Gene)
NOS3GeneProduct287024 (Entrez Gene)
RENGeneProduct511831 (Entrez Gene)

Annotated Interactions

No annotated interactions
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP1033"
Personal tools